SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-17-088186
Filing Date
2017-03-20
Accepted
2017-03-20 06:05:33
Documents
4
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d362047d10ka.htm 10-K/A 365480
2 EX-31.1 d362047dex311.htm EX-31.1 6450
3 EX-31.2 d362047dex312.htm EX-31.2 6441
4 EX-32.1 d362047dex321.htm EX-32.1 5007
  Complete submission text file 0001193125-17-088186.txt   384399
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37587 | Film No.: 17700014
SIC: 2834 Pharmaceutical Preparations